TETRAPHARMAKOS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
TETRAPHARMAKOS
Largest movements
- Receivables within one year +€8,724
new in 2025: €8,724
- Tangible fixed assets +€6,006
up €6,006 (+308%), from €1,951 to €7,957
- Deferred charges and accrued income -€5,154
down €5,154 (-10.4%), from €49,736 to €44,582
- Other debts +€56,043
up €56,043 (+34.8%), from €161,183 to €217,226
- Reserves -€25,000
down €25,000 (-17.2%), from €145,000 to €120,000
- Tax, wage and social debts -€22,159
down €22,159 (-59.7%), from €37,147 to €14,987
- Financial charges +€33,255
up €33,255 (+52.1%), from €63,854 to €97,109
- Gross operating margin -€27,489
down €27,489 (-13.8%), from €199,137 to €171,648
- Taxes -€14,597
down €14,597 (-48.9%), from €29,872 to €15,276
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €348,819 | €357,733 | +€8,915 | +2.6% |
| Fixed assets | 21/28 | €1,951 | €7,957 | +€6,006 | +308% |
| Tangible fixed assets | 22/27 | €1,951 | €7,957 | +€6,006 | +308% |
| Furniture and vehicles | 24 | €1,951 | €7,957 | +€6,006 | +308% |
| Current assets | 29/58 | €346,868 | €349,776 | +€2,908 | +0.8% |
| Amounts receivable within one year | 40/41 | - | €8,724 | +€8,724 | |
| Other amounts receivable | 41 | - | €8,724 | +€8,724 | |
| Cash at bank and in hand | 54/58 | €297,131 | €296,469 | -€662 | -0.2% |
| Deferred charges and accrued income | 490/1 | €49,736 | €44,582 | -€5,154 | -10.4% |
| Total equity and liabilities | 10/49 | €348,819 | €357,733 | +€8,915 | +2.6% |
| Equity | 10/15 | €150,120 | €125,000 | -€25,120 | -16.7% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €145,000 | €120,000 | -€25,000 | -17.2% |
| Distributable reserves | 133 | €145,000 | €120,000 | -€25,000 | -17.2% |
| Profit (loss) carried forward | 14 | €120 | - | -€120 | |
| Amounts payable | 17/49 | €198,699 | €232,733 | +€34,034 | +17.1% |
| Amounts payable within one year | 42/48 | €198,699 | €232,233 | +€33,534 | +16.9% |
| Trade debts | 44 | €369 | €19 | -€350 | -94.7% |
| Suppliers | 440/4 | €369 | €19 | -€350 | -94.7% |
| Taxes, remuneration and social security | 45 | €37,147 | €14,987 | -€22,159 | -59.7% |
| Taxes | 450/3 | €37,147 | €14,987 | -€22,159 | -59.7% |
| Other amounts payable | 47/48 | €161,183 | €217,226 | +€56,043 | +34.8% |
| Accrued charges and deferred income | 492/3 | - | €500 | +€500 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €779 | €1,033 | +€255 | +32.7% |
| Other operating charges | 640/8 | €601 | €164 | -€437 | -72.7% |
| Gross operating margin | 9900 | €199,137 | €171,648 | -€27,489 | -13.8% |
| Operating profit (loss) | 9901 | €197,758 | €170,451 | -€27,307 | -13.8% |
| Financial income | 75/76B | €0 | €64 | +€64 | +63,800% |
| Recurring financial income | 75 | €0 | €64 | +€64 | +63,800% |
| Financial charges | 65/66B | €63,854 | €97,109 | +€33,255 | +52.1% |
| Recurring financial charges | 65 | €63,854 | €97,109 | +€33,255 | +52.1% |
| Profit (loss) for the period before taxes | 9903 | €133,904 | €73,406 | -€60,498 | -45.2% |
| Income taxes | 67/77 | €29,872 | €15,276 | -€14,597 | -48.9% |
| Profit (loss) for the period | 9904 | €104,031 | €58,130 | -€45,901 | -44.1% |
| Profit (loss) for the period to be appropriated | 9905 | €104,031 | €58,130 | -€45,901 | -44.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.